| 000 | 01819 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516223650.0 | ||
| 264 | 0 | _c20150602 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1868-6982 | ||
| 024 | 7 |
_a10.1002/jhbp.131 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDokduang, Hasaya | |
| 245 | 0 | 0 |
_aSTATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. _h[electronic resource] |
| 260 |
_bJournal of hepato-biliary-pancreatic sciences _cOct 2014 |
||
| 300 |
_a767-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aBile Ducts, Intrahepatic |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aFascioliasis _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aSTAT Transcription Factors _xmetabolism |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aTechasen, Anchalee | |
| 700 | 1 | _aNamwat, Nisana | |
| 700 | 1 | _aKhuntikeo, Narong | |
| 700 | 1 | _aPairojkul, Chawalit | |
| 700 | 1 | _aMurakami, Yoshinori | |
| 700 | 1 | _aLoilome, Watcharin | |
| 700 | 1 | _aYongvanit, Puangrat | |
| 773 | 0 |
_tJournal of hepato-biliary-pancreatic sciences _gvol. 21 _gno. 10 _gp. 767-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jhbp.131 _zAvailable from publisher's website |
| 999 |
_c24026035 _d24026035 |
||